Navigation Links
Faster Approval Procedures Urged For New TB Drugs

Medicins Sans Frontiers(MSF), on Monday called for fast tracking of the approval procedures for drugs which are likely to be effective against extremely drug resistant// tuberculosis(XDR-TB) which is highly prevalent, especially in sub Saharan Africa.

MSF otherwise called Doctors Without Borders(DWB) has urged that the regulatory bodies like the US Food and Drug Administraton(USFDA) and European Medicines Agency step up their pace in developing the promising drugs and make them available.

It was thought earlier that TB had been contained and its eradication was only a matter of time. But the respiratory disease is now back in the form of a new virulent drug resistant strain. The World Health Organization(WHO) estimates that nearly 2 million people worldwide die of TB each year, 99% of them from developing countries.

People with HIV/AIDS are likelier to be susceptible to it because of their low immunity levels and one third of them are infected with TB.

Around 450,000 people are infected yearly with strains that resist treatment with first-line antibiotics, and an increasing number are also untreatable with second-line drugs, "making treatment with existing drugs virtually impossible," MSF said.

The head of Doctors Without Borders, Rowan Gillies, said that research into TB drugs has not been a priority for the past 40-50 years, and that the WHO should take the initiative to deal with this crisis immediately.

The first of the drugs in the pipeline is not going to be ready before 2010 at the current speed of operations, and others will be even more delayed.

Three other medicines are now in clinical trials -- Johnson & Johnson's Diarylquinoline, Otsuka's Nitroimidazo, and Pyrrole by Lupin Ltd and Tido von Schoen-Angerer, director of MSF's Campaign for Access to Essential Medicines, said that it is important that they be brought to the market quickly.

He said fast-tracki ng the three drugs could help curb the spreading of the difficult strains and urged the WHO to ensure adequate funding into TB research. He suggested that just as the first HIV drugs were made available even before final approval, the new TB drugs be given to the needy patients as soon as they were proven safe.
MAL
'"/>




Related medicine news :

1. Faster way of producing Bird flu vaccine using Reverse Genetics
2. Wounds Heal 25% Faster In Older Adults Who Exercise Regularly
3. Singapore’s Healthcare To Outsource To Indian Firm For Faster X-Ray Result
4. New Antibiotic For Faster Relief From Asthma
5. Adolescent Girls Have Faster Psychological Improvement Than Boys
6. A New break Through In Surgery May Help In Faster Recovery Of Patients
7. Bubble-Blowing Infants may Learn Language Skills Faster
8. Arrested Drug Offenders Offered Faster Help
9. Honey Works Faster than Antibiotics in Healing Wounds
10. New Research Suggests That Obesity Strikes Faster Growing Kids
11. Drug Prices Rising Faster Than Inflation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... July 27, 2017 , ... Standard Process is ushering in a new era ... North Carolina Research Campus (NCRC) in Kannapolis, North Carolina and by announcing a new ... fall of this year, occupying over 10,000 square feet on the first floor of ...
(Date:7/27/2017)... ... 2017 , ... For bicycling enthusiasts around the globe, Germany's famous Rad am ... against a backdrop of tree-lined hills at the Nürburgring, a Formula One arena known ... Ring consists of some 73 curves, stretching out over more than 500 meters of ...
(Date:7/27/2017)... (PRWEB) , ... July 28, 2017 , ... ... Syngenta on an upcoming episode of the award-winning television series, American Famer, scheduled ... on RFD-TV. , Syngenta is dedicated to helping humanity face its toughest ...
(Date:7/27/2017)... OH (PRWEB) , ... July 27, 2017 , ... ... Electronic Visit Verification to State Medicaid programs, Managed Care Organizations and Home Care ... 2017. , The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies ...
(Date:7/27/2017)... ... 2017 , ... GAFFEY Healthcare, a leading provider of revenue ... Vice President of Revenue Cycle Business Services and Suzanne Dusak to Vice President ... officer (CEO). , Elrene has been with company since Oct 2014 and previously ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
Breaking Medicine Technology: